Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis.

Fors, John; Strydom, Natasha; Fox, William S; Keizer, Ron J; Savic, Radojka M

Fors, John; Strydom, Natasha; Fox, William S; Keizer, Ron J; Savic, Radojka M.

Afiliação

Fors J; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, CA, United States of America.
Strydom N; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, CA, United States of America.
Fox WS; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, CA, United States of America.
Keizer RJ; InsightRX, San Francisco, CA, United States of America.
Savic RM; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, CA, United States of America.

PLoS Comput Biol ; 16(8): e1008107, 2020 08.

Article em En | MEDLINE | ID: mdl-32810158

Assuntos

Antituberculosos/uso terapêutico; Modelos Teóricos; Tuberculose Pulmonar/tratamento farmacológico; Antituberculosos/administração & dosagem; Antituberculosos/farmacocinética; Quimioterapia Combinada; Humanos; Adesão à Medicação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Modelos Teóricos / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Comput Biol Assunto da revista: BIOLOGIA / INFORMATICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google